Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1985-08-30
1987-10-06
Jiles, Henry R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546138, A61K 31345, C07D45502
Patent
active
046983490
ABSTRACT:
The invention relates to novel quinolizinone compounds, of inhibitory activity on allergies and ulcers, of the formula: ##STR1## wherein R.sup.1 is carboxy, carbamoyl Y.sup.1, phenylcarbamoyl which may have hydroxy, cyano or thiocarbamoyl,
REFERENCES:
Kappe, T. Chem Abstracts, vol. 67;82039q (1967).
Acheson et al., Chem Abstracts, vol. 62;16188h (1965).
Kappe et al, Chem Abstracts, vol. 99;88023n (1983).
Ibid, vol. 78;111166p (1973).
Thyagarajan et al., Chem Abstracts vol. 63;4255e (1965).
Allen et al., Chem Abstracts, vol. 54;1533e (1960).
Leaver et al. Chem Abstracts vol. 60; 54549 (1964).
Kobayashi et al, Chem Abstracts, vol. 88;44882k (1978).
Goodman et al., The Pharmacological Basis of Therapeutics 6 ed. p. 28.
Hashimoto Masashi
Hirai Hideo
Kitaura Yoshihiko
Oku Teruo
Yamamoto Tosiyuki
Fujisawa Pharmaceutical Co. Ltd.
Jiles Henry R.
Richter J.
LandOfFree
Quinolizinone compounds, and pharmaceutical composition comprisi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinolizinone compounds, and pharmaceutical composition comprisi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinolizinone compounds, and pharmaceutical composition comprisi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2117541